About HeartLung
HeartLung.AI is a health-tech company focused on leveraging artificial intelligence for the early detection and prevention of cardiovascular disease and lung cancer. Their mission is to shift healthcare from late-stage disease treatment to earlier identification and prevention by unlocking clinically actionable information embedded within routine medical imaging.
The company has developed several FDA-cleared and breakthrough-designated AI platforms. HeartLung’s AI-CVD platform allows for automated extraction of measurements from CT scans for comprehensive cardiovascular risk assessment. This includes AutoBMD, an FDA 510(k) cleared, DEXA-equivalent, CT-based opportunistic osteoporosis screening tool applicable to millions of CT scans annually. They also have AutoChamber AI, which received FDA “Breakthrough Designation” and marketing authorization for detecting enlarged cardiac chambers and left ventricular hypertrophy in non-contrast chest CT scans, often invisible to the human eye. HeartLung is also awaiting approval for AutoCAC (Automated Coronary Calcium Scoring) and other AI modules focusing on chest CT scans.
HeartLung’s AI solutions are designed to integrate into existing radiology workflows, providing automated, quantitative outputs that can help identify diseases like heart disease, lung cancer, COPD, osteoporosis, and fatty liver disease years before symptoms appear. Their technology aims to provide fast, actionable data for multiple diseases from a single chest CT scan, supporting population health and value-based care.
Focus Areas
Business Intelligence
| Technology | cloud-based, AI-powered quantitative imaging platform that integrates with existing PACS systems and delivers DICOMized PDF reports |
What Physicians Need to Know
HeartLung's AI solutions provide physicians with comprehensive, actionable insights from routine CT scans, enabling earlier detection, improved risk stratification, and timely preventive interventions for a wide range of cardiovascular, pulmonary, metabolic, and skeletal conditions. The AI-generated reports offer quantitative measurements that can enhance diagnostic accuracy and support clinical decision-making, potentially leading to better patient outcomes and reduced late-stage disease. The seamless integration with existing PACS and rapid AI turnaround within minutes allows for easy adoption without significant workflow changes.
HeartLung's services are designed for simple and easy workflow integration. Providers can set up an account quickly and install a HeartLung Gateway to automatically send scans to their cloud-based AI platform. AI-generated DICOMized PDF reports are then sent directly back to the facility's PACS. Referring physicians can also manually upload CT scans and receive instant AI-generated reports.
What the Web Says
HeartLung (also referred to as HeartLung Technologies or HeartLung.AI) is a health-tech company that develops AI-enabled solutions for the early detection of heart disease, lung cancer, osteoporosis, fatty liver disease, and other conditions using standard CT scans. Their flagship product, AI-CVD, is an FDA-cleared AI-powered quantitative imaging platform that can extract clinically relevant cardiovascular and systemic measurements from existing CT scans without additional imaging or workflow disruption. Employer reviews for "Heart Lung" (which may or may not be the same entity as HeartLung Technologies) are limited but generally positive, highlighting good learning opportunities and supportive staff.
Overall: PositiveStrengths
- AI-enabled solutions for early detection of various diseases using existing CT scans.
- FDA-cleared platform (AI-CVD) for comprehensive opportunistic screening.
- Automated extraction of clinically relevant measurements without additional radiation or contrast.
- Potential to identify patients at increased risk for earlier intervention and improved outcomes.
- Good learning experience and opportunities for advancement (based on limited employer reviews).
- Supportive staff and management (based on limited employer reviews).
Limitations
- Limited number of publicly available product reviews from major platforms like G2, Capterra, and Glassdoor.
- Employer reviews are scarce and may not be directly tied to HeartLung Technologies.
- Some Reddit discussions about AI in healthcare show general skepticism or concerns about anthropomorphizing AI.
- No specific negative product features or company culture issues were found in the available search results.
- Capterra and G2 show alternatives to HeartLung AI-CVD, but not direct negative reviews of HeartLung itself.
- The distinction between "Heart Lung" as an employer and "HeartLung Technologies" as a product company is not always clear in search results.
Based on reviews from: Indeed.com, HeartLung.AI, Diagnostic and Interventional Cardiology (DAIC), AuntMinnie, Reddit, G2, The National Law Review
Last updated: 2026-10-23
Videos
News, demos, and interviews about HeartLung.
Videos load interactively. If none appear, search YouTube for HeartLung →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]